Pharmaceutical preparation comprising vWF propeptide
AssigneeBaxter Aktiengesellschaft
InventorsHans-Peter Schwarz, Katalin Varadi, Peter Turecek, Hendrik Coenraad Hemker, Suzette Lucette Beguin
Life of this patent
Estimating the term…
Abstract
Described is a pharmaceutical preparation for treating blood coagulation disorders comprising an effective amount of vWf propeptide as well as a method for producing such a prepartion.
Claims5
A pharmaceutical preparation for treating blood coagulation disorders, said preparation comprising at least 10 nM von Willebrand Factor (vWF) propeptide and a hemostasis protein, wherein said preparation has been treated for at least one of virus inactivation and virus removal so the preparation is suitable for therapeutic administration.
A pharmaceutical preparation for treating blood coagulation disorders, said preparation comprising at least 10 nM von Willebrand Factor (vWF) propeptide and a phospholipid, wherein the preparation has been treated for at least one of virus inactivation and virus removal so the preparation is suitable for therapeutic administration.
A pharmaceutical preparation for treating blood coagulation disorders, said preparation comprising at least 10 nM von Willebrand Factor (vWF) propeptide and at least two components, wherein the components are selected from the group consisting of a blood factor, a platelet component, and a phospholipid, wherein said preparation has been treated for at least one of virus inactivation and virus removal so the preparation is suitable for therapeutic administration.
Dependencies are inferred from the claim text.